Immunotherapy for the Prevention and Treatment of Type 1 Diabetes Optimizing the path from bench to bedside

被引：28

作者：

Bresson, Damien ^{[1
]}

von Herrath, Matthias ^{[1
]}

机构：

[1] La Jolla Inst Allergy & Immunol, Ctr Type Diabet Res 1, La Jolla, CA USA

来源：

DIABETES CARE | 2009年 / 32卷 / 10期

关键词：

BETA-CELL FUNCTION; ANTI-CD3; MONOCLONAL-ANTIBODY; EPIDERMAL-GROWTH-FACTOR; CD4(+) T-CELLS; TRANSLATIONAL MINIREVIEW SERIES; POTENTIAL CLINICAL-RELEVANCE; PROTEIN PEPTIDE DIAPEP277; GLUCAGON-LIKE PEPTIDE-1; PANCREATIC-DUCT CELLS; COMBINATION THERAPY;

D O I：

10.2337/dc09-0373

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1753 / 1768

页数：16

共 127 条

[31] Exendin-4 modulates diabetes onset in nonobese diabetic mice [J].

Hadjiyanni, Irene ;

Baggio, Laurie L. ;

Poussier, Philippe ;

Drucker, Daniel J. .

ENDOCRINOLOGY, 2008, 149 (03) :1338-1349

[32] Pancreatic β-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes [J].

Harrison, LC ;

Honeyman, MC ;

Steele, CE ;

Stone, NL ;

Sarugeri, E ;

Bonifacio, E ;

Couper, E ;

Couper, JJ ;

Colman, PG .

DIABETES CARE, 2004, 27 (10) :2348-2355

[33] HIGH-DOSE NICOTINAMIDE FAILS TO PREVENT DIABETES IN BB RATS [J].

HERMITTE, L ;

VIALETTES, B ;

ATLEF, N ;

PAYAN, MJ ;

DOLL, N ;

SCHEIMANN, A ;

VAGUE, P .

AUTOIMMUNITY, 1989, 5 (1-2) :79-86

[34] A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes [J].

Herold, KC ;

Gitelman, SE ;

Masharani, U ;

Hagopian, W ;

Bisikirska, B ;

Donaldson, D ;

Rother, K ;

Diamond, B ;

Harlan, DM ;

Bluestone, JA .

DIABETES, 2005, 54 (06) :1763-1769

[35] Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala) [J].

Herold, KC ;

Burton, JB ;

Francois, F ;

Poumian-Ruiz, E ;

Glandt, M ;

Bluestone, JA .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) :409-418

[36] Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus [J].

Herold, KC ;

Hagopian, W ;

Auger, JA ;

Poumian-Ruiz, E ;

Taylor, L ;

Donaldson, D ;

Gitelman, SE ;

Harlan, DM ;

Xu, DL ;

Zivin, RA ;

Bluestone, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22) :1692-1698

[37]

Hinke SA, 2008, CURR OPIN MOL THER, V10, P516

[38]

Homann D, 1999, J IMMUNOL, V163, P1833

[39] Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/stat6 pathway [J].

Homann, D ;

Holz, A ;

Bot, A ;

Coon, B ;

Wolfe, T ;

Petersen, J ;

Dyrberg, TP ;

Grusby, MJ ;

von Herrath, MG .

IMMUNITY, 1999, 11 (04) :463-472

[40] Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice [J].

Hu, Chang-Yun ;

Rodriguez-Pinto, Daniel ;

Du, Wei ;

Ahuja, Anupama ;

Henegariu, Octavian ;

Wong, F. Susan ;

Shlornchik, Mark J. ;

Wen, Li .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :3857-3867

← 1 2 3 4 5 6 7 8 9 10 →